VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy
Clinical trial NCT05920343 · RECRUITING
Trial details
- NCT number
- NCT05920343
- Sponsor
- Ottawa Hospital Research Institute
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2026-10-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.